Raymond James & Associates’s NexImmune, Inc. Common Stock NEXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.7K | Hold |
10,804
| – | – | ﹤0.01% | 3934 |
|
|
2024
Q2 | $29.8K | Hold |
10,804
| – | – | ﹤0.01% | 3805 |
|
|
2024
Q1 | $60.6K | Buy |
+10,804
| New | +$60.6K | ﹤0.01% | 3747 |
|
|
2023
Q4 | – | Sell |
-12,825
| Closed | -$67.3K | – | 3910 |
|
|
2023
Q3 | $67.3K | Hold |
12,825
| – | – | ﹤0.01% | 3617 |
|
|
2023
Q2 | $90.4K | Hold |
12,825
| – | – | ﹤0.01% | 3603 |
|
|
2023
Q1 | $122K | Buy |
12,825
+11,600
| +947% | +$110K | ﹤0.01% | 3569 |
|
|
2022
Q4 | $7.44K | Hold |
1,225
| – | – | ﹤0.01% | 3761 |
|
|
2022
Q3 | $17K | Hold |
1,225
| – | – | ﹤0.01% | 3739 |
|
|
2022
Q2 | $49K | Buy |
1,225
+400
| +48% | +$16K | ﹤0.01% | 3734 |
|
|
2022
Q1 | $87K | Buy |
+825
| New | +$87K | ﹤0.01% | 3791 |
|
|
2021
Q4 | – | Sell |
-1,038
| Closed | -$393K | – | 4093 |
|
|
2021
Q3 | $393K | Buy |
+1,038
| New | +$393K | ﹤0.01% | 3219 |
|